[July 01, 2016]

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 2016 - Research and Markets

Research and Markets has announced the addition of the "End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce firs-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Overview
3. Therapeutics Development
4. Pipeline Products for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
5. Pipeline Products for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Comparative Analysis
6. End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics under Development by Companies
7. End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics under Investigation by Universities/Institutes
8. End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Products under Development by Companies
13. End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Products under Investigation by Universities/Institutes
14. End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Companies Involved in Therapeutics Development

• Acceleron Pharma, Inc.
• Bayer AG
• BioAegis Therapeutics, Inc.
• F. Hoffmann-La Roche Ltd.
• Ionis Pharmaceuticals, Inc.
• Prolong Pharmaceuticals, LLC

For more information visit http://www.researchandmarkets.com/research/g3r6qj/endstage_kidney

View source version on businesswire.com: http://www.businesswire.com/news/home/20160701005246/en/

[ Back To TMCnet.com's Homepage ]